Contact this trialFirst, we need to learn more about you.
Imipridone DRD2 Antagonist
ONC201 for Brain Tumor
Recruiting1 awardPhase 2
Charlotte, North Carolina
This trial tests ONC201, a pill that targets proteins, in adults with recurring aggressive brain cancer. It works by blocking a protein that helps cancer cells grow. ONC201 has shown anti-cancer activity in various types of cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service